Cellular and pathological functions of tau

C Parra Bravo, SA Naguib, L Gan - Nature Reviews Molecular Cell …, 2024 - nature.com
Tau protein is involved in various cellular processes, including having a canonical role in
binding and stabilization of microtubules in neurons. Tauopathies are neurodegenerative …

Phosphorylated tau in Alzheimer's disease and other tauopathies

P Rawat, U Sehar, J Bisht, A Selman… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia in elderly people. Amyloid beta
(Aβ) deposits and neurofibrillary tangles are the major pathological features in an …

Tau and neuroinflammation in Alzheimer's disease: Interplay mechanisms and clinical translation

Y Chen, Y Yu - Journal of neuroinflammation, 2023 - Springer
Alzheimer's Disease (AD) contributes to most cases of dementia. Its prominent
neuropathological features are the extracellular neuritic plaques and intercellular …

O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathology

AT Balana, AL Mahul-Mellier, BA Nguyen… - Nature chemical …, 2024 - nature.com
Amyloid-forming proteins such α-synuclein and tau, which are implicated in Alzheimer's and
Parkinson's disease, can form different fibril structures or strains with distinct toxic properties …

[HTML][HTML] Glycosylation and behavioral symptoms in neurological disorders

P Pradeep, H Kang, B Lee - Translational Psychiatry, 2023 - nature.com
Glycosylation, the addition of glycans or carbohydrates to proteins, lipids, or other glycans, is
a complex post-translational modification that plays a crucial role in cellular function. It is …

Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases

MR Pratt, DJ Vocadlo - Journal of Biological Chemistry, 2023 - ASBMB
O-GlcNAc is a common modification found on nuclear and cytoplasmic proteins.
Determining the catalytic mechanism of the enzyme O-GlcNAcase (OGA), which removes O …

[HTML][HTML] O-GlcNAcylation in tumorigenesis and its implications for cancer therapy

D Zhang, Y Qi, H Inuzuka, J Liu, W Wei - Journal of Biological Chemistry, 2024 - Elsevier
Abstract O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a dynamic and reversible
posttranslational modification that targets serine and threonine residues in a variety of …

Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?

V Brembati, G Faustini, F Longhena… - Frontiers in molecular …, 2023 - frontiersin.org
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …

[HTML][HTML] Protein glycosylation and glycoinformatics for novel biomarker discovery in neurodegenerative diseases

J Costa, C Hayes, F Lisacek - Ageing research reviews, 2023 - Elsevier
Glycosylation is a common post-translational modification of brain proteins including cell
surface adhesion molecules, synaptic proteins, receptors and channels, as well as …

Discovery of 4-(Arylethynyl)piperidine Derivatives as Potent Nonsaccharide O-GlcNAcase Inhibitors for the Treatment of Alzheimer's Disease

Z Cheng, N Shang, X Wang, Y Kang… - Journal of Medicinal …, 2024 - ACS Publications
Inhibiting O-GlcNAcase and thereby up-regulation of the O-GlcNAc levels of tau was a
potential approach for discovering AD treatments. Herein, a series of novel highly potent …